US FDA approves MannKind's inhaled insulin for children
- Posted on May 29, 2026
- By Bing News
- 0 Views
- 1 min read
US FDA approves MannKind's inhaled insulin for children
By Sahil Pandey and Sriparna Roy May 29 (Reuters) - The U.S. Food and Drug Administration has approved expanded use of MannKind's inhaled rapid-acting insulin in children with diabetes, offering patients under 18 years of age a needle-free treatment option, the company said on Friday. Shares of the company were up 6% in afternoon trading. The approval broadens treatment options for younger
